Brief: Tarsus Pharmaceuticals posts Q1 EPS USD -0.88
09/05/2023 23:05
May 9 (Reuters) - Tarsus Pharmaceuticals Q1 operating expenses USD 27.452 million. * Q1 net income USD -23.419 million * Q1 EPS USD -0.88 * Q1 basic EPS USD -0.88
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)